Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2023-10-29 Interim / Quarterly Rep…
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2023 Third Quarter Report" of Shanghai Chenguang Medical Technology Co., Ltd. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial changes for the period ending September 30, 2023. The document explicitly states it is a quarterly report (third quarter) and includes comprehensive financial statements and management commentary. It is not an announcement or a brief summary but a full financial report for a period shorter than a fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-29 Chinese
第五届监事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Shanghai Chenguang Medical Technology Co., Ltd. It details the convening and attendance of the meeting, the approval of the 2023 third quarter report, and the voting results. The document does not contain the actual financial data or the full quarterly report itself but references the report published on the Beijing Stock Exchange information disclosure platform. The document is a formal announcement of the Supervisory Board's resolution regarding the quarterly report, not the report itself. Given the nature of the document as a meeting resolution announcement related to the supervisory board and the approval of a report, it fits best under Board/Management Information (MANG). The document length is short and it does not contain substantive financial data, so it is not an Interim/Quarterly Report (IR).
2023-10-29 Chinese
上海辰光医疗科技股份有限公司2023年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions passed at the 2023 fourth extraordinary general meeting of shareholders of Shanghai Chenguang Medical Technology Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the voting outcomes and procedural compliance rather than presenting a full report or financial statements. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4100 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation. Therefore, the appropriate classification is DVA with high confidence.
2023-10-11 Chinese
关于上海辰光医疗科技股份有限公司2023年第四次临时股东大会之法律意见书
Regulatory Filings
2023-10-11 Chinese
上海辰光医疗科技股份有限公司章程
Governance Information Classification · 100% confidence The document is titled "上海辰光医疗科技股份有限公司 公司章程" which translates to "Shanghai Chenguang Medical Technologies Co., Ltd. Articles of Association." The content includes detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, shareholder meetings, and governance rules. It is a comprehensive set of corporate bylaws or articles of association that govern the company's internal rules, board structure, shareholder meetings, and governance practices. There is no indication that this is an annual report, financial statement, earnings release, or any other type of financial or regulatory filing. Instead, it fits the description of a Governance Information report, which details the company's internal rules, board structure, and governance practices. The document length is substantial (15,000 characters), and it is not an announcement or a brief notice. Therefore, the appropriate classification is Governance Information (CGR).
2023-10-11 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement about obtaining an invention patent certificate. It details the patent name, number, and its significance to the company. There is no financial data, no mention of financial results, no regulatory filings, or meeting materials. It is a regulatory announcement related to intellectual property rights. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a general regulatory announcement about a patent grant, which fits best under Regulatory Filings (RNS). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is Regulatory Filings (RNS).
2023-09-25 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.